Invention Grant
- Patent Title: Treatment of triple receptor negative breast cancer
- Patent Title (中): 三联受体阴性乳腺癌的治疗
-
Application No.: US12293039Application Date: 2007-03-16
-
Publication No.: US08168216B2Publication Date: 2012-05-01
- Inventor: Kay-Oliver Kliche , Axel Mescheder , Martine Piccart
- Applicant: Kay-Oliver Kliche , Axel Mescheder , Martine Piccart
- Applicant Address: DE Planegg/Martinsried
- Assignee: MediGene AG
- Current Assignee: MediGene AG
- Current Assignee Address: DE Planegg/Martinsried
- Agency: Milbank, Tweed, Hadley & McCloy, LLP
- Priority: EP06005893 20060322
- International Application: PCT/EP2007/002352 WO 20070316
- International Announcement: WO2007/107305 WO 20070927
- Main IPC: A61K9/127
- IPC: A61K9/127
Abstract:
The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of ‘triple receptor negative’ breast cancer.
Public/Granted literature
- US20090186078A1 TREATMENT OF TRIPLE RECEPTOR NEGATIVE BREAST CANCER Public/Granted day:2009-07-23
Information query
